A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is
Long term virological follow up of Hepatitis C (VHC) monoinfected patients who achieved end of treatment response (ETR)
International Journal of Infectious Diseases
Abstracts nucleos(t)ide analogues. Patients were evaluated based on virologic and serologic response to therapy, and were classified as patients with a detectable level of HBV DNA and undetectable HBV DNA (<1.08 log copies/ml). The mutations associated with HBV drug resistance were investigated in patients with detectable HBV DNA. Due to resistance, in this group of patients treatment was change. Results: In our study group, four patients developed LAM-associated mutations (rtL180M+rtM204V,doi:10.1016/j.ijid.2010.02.2009 fatcat:hqui4aufkfdrlhiibcmb4xszvi